These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20298986)

  • 21. Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study?
    Kent DM; Kitsios GD
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):414-5. PubMed ID: 22592756
    [No Abstract]   [Full Text] [Related]  

  • 22. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.
    Chessa M; Colombo C; Butera G; Negura D; Piazza L; Varotto L; Bussadori C; Fesslova V; Meola G; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):401-5. PubMed ID: 19449455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D; Fabbiocchi F; Montorsi P; Galli S; Teruzzi G; Grancini L; Gatto P; Bartorelli AL
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):570-4. PubMed ID: 21351231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip.
    Fanari Z; Hammami S; Hopkins JT
    Del Med J; 2016 Aug; 88(8):238-241. PubMed ID: 28751787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioembolic stroke: who is the guilty?
    Gaio G; Santoro G; Palladino MT; Iacono C; Castaldi B; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):370-2. PubMed ID: 20613549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a predominant left-to-right shunt associated with migraine?: A prospective atrial septal defect closure study.
    Luermans JG; Post MC; Temmerman F; Thijs V; Schonewille WJ; Plokker HW; Ten Berg JM; Suttorp MJ; Budts WI
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1078-84. PubMed ID: 19739264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The paradox of paradoxical embolism and recurrent stroke.
    Abou-Chebl A
    JACC Cardiovasc Interv; 2014 Aug; 7(8):921-2. PubMed ID: 25147038
    [No Abstract]   [Full Text] [Related]  

  • 30. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent foramen ovale.
    Silva GV
    Tex Heart Inst J; 2014 Jun; 41(3):306-8. PubMed ID: 24955048
    [No Abstract]   [Full Text] [Related]  

  • 33. Closure of patent foramen ovale: The abolition of stroke and asymptotic realities.
    Tan WA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):517-8. PubMed ID: 15274164
    [No Abstract]   [Full Text] [Related]  

  • 34. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
    Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke.
    Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD
    Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explantation of patent foramen ovale closure devices: a multicenter survey.
    Verma SK; Tobis JM
    JACC Cardiovasc Interv; 2011 May; 4(5):579-85. PubMed ID: 21596333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second device for a patent foramen ovale: life saver and psychotherapy.
    Meier B
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):151-2. PubMed ID: 20578221
    [No Abstract]   [Full Text] [Related]  

  • 39. Should we close hypoxaemic patent foramen ovale and interatrial shunts on a systematic basis?
    Juliard JM; Aubry P; Ducrocq G; Lepage L; Brochet E
    Arch Cardiovasc Dis; 2009 Nov; 102(11):739-41. PubMed ID: 19944388
    [No Abstract]   [Full Text] [Related]  

  • 40. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.